Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome

J. M. Anaya, Howard S Mcguff, P. M. Banks, N. Talal

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

This study was undertaken to summarize the current status of the clinicopathologic factors related to non-Hodgkin's lymphoma (NHL) development in patients with Sjogren's syndrome (SS). Through a MEDLINE search, pertinent articles on SS, monoclonality, and NHL were found and reviewed. Malignant lymphoma description was based on the International Lymphoma Study Group classification. Patients with SS are known to have an increased risk for developing B-cell NHL (B-NHL). However, such a complication occurs in less than 10% of patients, being reported mainly in those with primary SS. Extranodal low-grade B-NHL are observed most frequently. Persistent enlargement of parotid glands, adenopathy, monoclonal gammopathy, and cross- reactive idiotypes are all signs suggesting possible lymphoma evolution. Although monoclonality does not mean malignancy unequivocally, it is considered to be a precursor for NHL development in SS. Factors implicated into lymphomagenesis in SS include dysregulation in the mechanisms leading to apoptosis, hyperstimulation of B-1 cells, and an infectious agent. Polyclonal lymphoproliferation characterizing SS might in some instances transform into monoclonal, and then to malignancy. Further studies on the mechanism whereby NHL develops in SS are warranted.

Original languageEnglish (US)
Pages (from-to)337-346
Number of pages10
JournalSeminars in Arthritis and Rheumatism
Volume25
Issue number5
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Sjogren's Syndrome
Lymphoma
Non-Hodgkin's Lymphoma
Paraproteinemias
Parotid Gland
B-Cell Lymphoma
MEDLINE
Neoplasms
B-Lymphocytes
Apoptosis

Keywords

  • apoptosis
  • monoclonality
  • non-Hodgkin's lymphoma
  • Sjogren's syndrome

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Orthopedics and Sports Medicine
  • Rheumatology

Cite this

Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome. / Anaya, J. M.; Mcguff, Howard S; Banks, P. M.; Talal, N.

In: Seminars in Arthritis and Rheumatism, Vol. 25, No. 5, 1996, p. 337-346.

Research output: Contribution to journalArticle

@article{aa6245a7589c4c4b8925fc6d286c29c6,
title = "Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome",
abstract = "This study was undertaken to summarize the current status of the clinicopathologic factors related to non-Hodgkin's lymphoma (NHL) development in patients with Sjogren's syndrome (SS). Through a MEDLINE search, pertinent articles on SS, monoclonality, and NHL were found and reviewed. Malignant lymphoma description was based on the International Lymphoma Study Group classification. Patients with SS are known to have an increased risk for developing B-cell NHL (B-NHL). However, such a complication occurs in less than 10{\%} of patients, being reported mainly in those with primary SS. Extranodal low-grade B-NHL are observed most frequently. Persistent enlargement of parotid glands, adenopathy, monoclonal gammopathy, and cross- reactive idiotypes are all signs suggesting possible lymphoma evolution. Although monoclonality does not mean malignancy unequivocally, it is considered to be a precursor for NHL development in SS. Factors implicated into lymphomagenesis in SS include dysregulation in the mechanisms leading to apoptosis, hyperstimulation of B-1 cells, and an infectious agent. Polyclonal lymphoproliferation characterizing SS might in some instances transform into monoclonal, and then to malignancy. Further studies on the mechanism whereby NHL develops in SS are warranted.",
keywords = "apoptosis, monoclonality, non-Hodgkin's lymphoma, Sjogren's syndrome",
author = "Anaya, {J. M.} and Mcguff, {Howard S} and Banks, {P. M.} and N. Talal",
year = "1996",
doi = "10.1016/S0049-0172(96)80019-9",
language = "English (US)",
volume = "25",
pages = "337--346",
journal = "Seminars in Arthritis and Rheumatism",
issn = "0049-0172",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome

AU - Anaya, J. M.

AU - Mcguff, Howard S

AU - Banks, P. M.

AU - Talal, N.

PY - 1996

Y1 - 1996

N2 - This study was undertaken to summarize the current status of the clinicopathologic factors related to non-Hodgkin's lymphoma (NHL) development in patients with Sjogren's syndrome (SS). Through a MEDLINE search, pertinent articles on SS, monoclonality, and NHL were found and reviewed. Malignant lymphoma description was based on the International Lymphoma Study Group classification. Patients with SS are known to have an increased risk for developing B-cell NHL (B-NHL). However, such a complication occurs in less than 10% of patients, being reported mainly in those with primary SS. Extranodal low-grade B-NHL are observed most frequently. Persistent enlargement of parotid glands, adenopathy, monoclonal gammopathy, and cross- reactive idiotypes are all signs suggesting possible lymphoma evolution. Although monoclonality does not mean malignancy unequivocally, it is considered to be a precursor for NHL development in SS. Factors implicated into lymphomagenesis in SS include dysregulation in the mechanisms leading to apoptosis, hyperstimulation of B-1 cells, and an infectious agent. Polyclonal lymphoproliferation characterizing SS might in some instances transform into monoclonal, and then to malignancy. Further studies on the mechanism whereby NHL develops in SS are warranted.

AB - This study was undertaken to summarize the current status of the clinicopathologic factors related to non-Hodgkin's lymphoma (NHL) development in patients with Sjogren's syndrome (SS). Through a MEDLINE search, pertinent articles on SS, monoclonality, and NHL were found and reviewed. Malignant lymphoma description was based on the International Lymphoma Study Group classification. Patients with SS are known to have an increased risk for developing B-cell NHL (B-NHL). However, such a complication occurs in less than 10% of patients, being reported mainly in those with primary SS. Extranodal low-grade B-NHL are observed most frequently. Persistent enlargement of parotid glands, adenopathy, monoclonal gammopathy, and cross- reactive idiotypes are all signs suggesting possible lymphoma evolution. Although monoclonality does not mean malignancy unequivocally, it is considered to be a precursor for NHL development in SS. Factors implicated into lymphomagenesis in SS include dysregulation in the mechanisms leading to apoptosis, hyperstimulation of B-1 cells, and an infectious agent. Polyclonal lymphoproliferation characterizing SS might in some instances transform into monoclonal, and then to malignancy. Further studies on the mechanism whereby NHL develops in SS are warranted.

KW - apoptosis

KW - monoclonality

KW - non-Hodgkin's lymphoma

KW - Sjogren's syndrome

UR - http://www.scopus.com/inward/record.url?scp=0029989203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029989203&partnerID=8YFLogxK

U2 - 10.1016/S0049-0172(96)80019-9

DO - 10.1016/S0049-0172(96)80019-9

M3 - Article

C2 - 8778989

AN - SCOPUS:0029989203

VL - 25

SP - 337

EP - 346

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

SN - 0049-0172

IS - 5

ER -